BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3465278)

  • 1. Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects.
    Leckman JF; Ort S; Caruso KA; Anderson GM; Riddle MA; Cohen DJ
    Arch Gen Psychiatry; 1986 Dec; 43(12):1168-76. PubMed ID: 3465278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine metabolism during clonidine withdrawal.
    Martin PR; Ebert MH; Gordon EK; Weingartner H; Kopin IJ
    Psychopharmacology (Berl); 1984; 84(1):58-63. PubMed ID: 6436892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine in the treatment of Tourette's syndrome exacerbation due to haloperidol withdrawal.
    Max JE; Rasmussen SA
    J Nerv Ment Dis; 1986 Apr; 174(4):243-6. PubMed ID: 3457098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-injurious behavior associated with clonidine withdrawal in a child with Tourette's disorder.
    Dillon JE
    J Child Neurol; 1990 Oct; 5(4):308-10. PubMed ID: 2246483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole blood serotonin and tryptophan levels in Tourette's disorder: effects of acute and chronic clonidine treatment.
    Leckman JF; Anderson GM; Cohen DJ; Ort S; Harcherik DF; Hoder EL; Shaywitz BA
    Life Sci; 1984 Dec; 35(25):2497-503. PubMed ID: 6595491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic clonidine treatment in Tourette's syndrome: a preliminary report on clinical response and effect on plasma and urinary catecholamine metabolites, growth hormone, and blood pressure.
    Leckman JF; Detlor J; Harcherik DF; Young JG; Anderson GM; Shaywitz BA; Cohen DJ
    J Am Acad Child Psychiatry; 1983 Sep; 22(5):433-40. PubMed ID: 6579101
    [No Abstract]   [Full Text] [Related]  

  • 7. Clonidine in Tourette's syndrome.
    Cohen DJ; Young JG; Nathanson JA; Shaywitz BA
    Lancet; 1979 Sep; 2(8142):551-3. PubMed ID: 89558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonidine treatment of Gilles de la Tourette's syndrome.
    Leckman JF; Hardin MT; Riddle MA; Stevenson J; Ort SI; Cohen DJ
    Arch Gen Psychiatry; 1991 Apr; 48(4):324-8. PubMed ID: 2009034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient exacerbation of tics in treatment of Tourette's syndrome with clonidine.
    Huk SG
    J Am Acad Child Adolesc Psychiatry; 1989 Jul; 28(4):583-6. PubMed ID: 2768153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective.
    Leckman JF; Detlor J; Harcherik DF; Ort S; Shaywitz BA; Cohen DJ
    Neurology; 1985 Mar; 35(3):343-51. PubMed ID: 3883235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
    Hunyor SN; Hansson L; Harrison TS; Hoobler SW
    Br Med J; 1973 Apr; 2(5860):209-11. PubMed ID: 4700009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clonidine on platelet alpha 2-adrenoreceptors and plasma norepinephrine of children with Tourette syndrome.
    Silverstein F; Smith CB; Johnston MV
    Dev Med Child Neurol; 1985 Dec; 27(6):793-9. PubMed ID: 3005096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.
    Reid JL; Wing LM; Dargie HJ; Hamilton CA; Davies DS; Dollery CT
    Lancet; 1977 Jun; 1(8023):1171-4. PubMed ID: 68274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment.
    Singer HS; Gammon K; Quaskey S
    Pediatr Neurosci; 1985-1986; 12(2):71-4. PubMed ID: 3870139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine in the treatment of Tourette syndrome: a review of data.
    Leckman JF; Cohen DJ; Detlor J; Young JG; Harcherik D; Shaywitz BA
    Adv Neurol; 1982; 35():391-401. PubMed ID: 6756089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of Tourette's syndrome and associated disorders.
    Cohen DJ; Riddle MA; Leckman JF
    Psychiatr Clin North Am; 1992 Mar; 15(1):109-29. PubMed ID: 1549543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
    Goodman WK; Charney DS; Price LH; Woods SW; Heninger GR
    Am J Psychiatry; 1986 Jul; 143(7):900-3. PubMed ID: 2872826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications for clonidine in child psychiatry].
    Dollfus S
    Encephale; 1993; 19(2):83-7. PubMed ID: 8275901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
    Campbell BC; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of endogenous dopamine metabolism in Gilles de la Tourette's disease.
    Messiha FS; Knopp W
    Dis Nerv Syst; 1976 Aug; 37(8):470-3. PubMed ID: 1066216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.